ITEMS IN AFP WITH KEYWORD:
Once-weekly subcutaneous semaglutide used as an adjunct to intensive behavioral therapy significantly improves the likelihood that adults without diabetes who are overweight or obese will lose at least 5% of their baseline body weight compared with placebo.
Based on population registry data, bariatric surgery is associated with lower all-cause mortality and a lower risk of developing many subsequent obesity-related conditions.
A 50-year-old patient, M.W., successfully reached their goal weight by losing 15 lb (6.8 kg) over six months on a Mediterranean diet. After maintaining the weight loss for more than a year, my patient is now 30 lb (13.6 kg) over their ideal body weight of 140 lb (63.5 kg).
Individual dietary interventions alone fail to change body mass index or the standardized BMI z-score across all age groups. The impact of regular physical activity or combined dietary and physical activity interventions is modest at best.
Key clinical questions and their evidence-based answers directly from the journal's content, written by and for family physicians.
Apr 15, 2019 Issue
Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults [Putting Prevention into Practice]
A.C., a 32-year-old woman, presents for her annual wellness visit. She recently had blood work completed that showed normal glucose and lipid levels. Her blood pressure is 124/76 mm Hg, weight is 221.8 lb (100.6 kg), height is 5 feet 6 inches (172 cm), and body mass index (BMI) is 34 kg per m2; examination of her heart and lungs is normal.
Apr 15, 2019 Issue
Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.
Lorcaserin, 10 mg twice daily, helps some patients lose 10% or more of their body weight (number needed to treat [NNT] = 10) and appears to be safe in terms of cardiovascular events.
Mar 1, 2019 Issue
Metformin for Improving Maternal and Infant Outcomes in Pregnant Women Who Are Obese [Medicine by the Numbers]
This meta-analysis showed no clear benefit for metformin in reducing the risk of large for gestational age infants. Additionally, there was no difference in important secondary outcomes such as gestational diabetes, hypertensive disease in pregnancy, shoulder dystocia, advanced perineal lacerations,...
Aug 1, 2018 Issue
Interventions for Treatment of Overweight and Obese Children [Cochrane for Clinicians]
Interventions that include combinations of diet, physical activity, and behavior changes may reduce weight, body mass index (BMI), and BMI z-score (equivalent to BMI-for-age percentile) in overweight and obese children six to 11 years of age.